180 related articles for article (PubMed ID: 21665504)
1. Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child.
Piermarocchi S; Benetti E; Fracasso G
J AAPOS; 2011 Jun; 15(3):314-6. PubMed ID: 21665504
[TBL] [Abstract][Full Text] [Related]
2. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN A CASE OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO TRAUMATIC CHOROIDAL RUPTURE.
Preziosa C; Corvi F; Pellegrini M; Bochicchio S; Rosar AP; Staurenghi G
Retin Cases Brief Rep; 2020; 14(4):339-342. PubMed ID: 29553995
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture.
Liang F; Puche N; Soubrane G; Souied EH
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1285-8. PubMed ID: 19468741
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
[TBL] [Abstract][Full Text] [Related]
5. Photoreceptor reconstitution correlates with visual improvement after intravitreal bevacizumab treatment of choroidal neovascularization secondary to traumatic choroidal rupture.
Francis JH; Freund KB
Retina; 2011 Feb; 31(2):422-4. PubMed ID: 21240036
[No Abstract] [Full Text] [Related]
6. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB
Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.
Knape RM; Zavaleta EM; Clark CL; Khuddus N; Peden MC
J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
[TBL] [Abstract][Full Text] [Related]
9. Choroidal neovascularization in a patient with blunt trauma-caused traumatic retinopathy without choroidal rupture.
Takahashi M; Kinoshita S; Saito W; Kase M; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):137-40. PubMed ID: 20714747
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
[TBL] [Abstract][Full Text] [Related]
13. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
Laud K; Spaide RF; Freund KB; Slakter J; Klancnik JM
Retina; 2006 Oct; 26(8):960-3. PubMed ID: 17031300
[No Abstract] [Full Text] [Related]
14. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
15. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
Derriman L; Marshall J; Moorman C; Downes SM
Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
[No Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
Artunay O; Rasier R; Yuzbasioglu E; Sengül A; Bahcecioglu H
Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
[TBL] [Abstract][Full Text] [Related]
17. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
Teixeira A; Moraes N; Farah ME; Bonomo PP
Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Bom Aggio F; Eid Farah M; Melo GB
Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
[No Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Spandau UH; Jonas JB
Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
